Note: Ingredients listed on restricted chemical lists
EC/CAS
57-50-1
Name of the chemical
Sucrose, pure C12H22O11
Concentration
N/A
EC/CAS
9005-65-6
Name of the chemical
polyethyleneglycol sorbitan monooleate
Concentration
N/A
EC/CAS
200-334-9
Name of the chemical
Sucrose, pure C12H22O11
Concentration
N/A
General Information
Revision date
2011-06-28
Product name
BeneFIX
Product Synonyms
Recombinant Coagulation Factor IX; nonacog alfa
Chemical name
Recombinant protein
Icons in SDS
Company Information
company name
Pfizer Inc
e-mail address of the competent person responsible for the Safety Data Sheet
pfizer-MSDS@pfizer.com
GHS Information
Signal word
WARNING
Section 2
SECTION 2: Hazards identification
Appearance: Powder
Signal word
WARNING
Hazard statements
May cause allergic skin reaction.
Additional information
Short Term: May cause allergic reaction . Pharmaceutical blood clotting agent: may be fatal if injected or enters bloodstream Known Clinical Effects: This product contains protein of bovine origin. Those with known sensitivity should avoid contact. Serious allergic reactions, including anaphylaxis, have been reported. Extensive intravascular clotting and death may result if injected or allowed to enter large blood vessels.
EU Classification
EU Indication of danger: Irritant EU Hazard Symbols: EU Risk Phrases: R43 - May cause sensitization by skin contact. Australian Hazard Classification
Hazardous Ingredients
Non-Dangerous Goods (NOHSC): Note: This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the active substance or its intermediates regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.
